Implanet received approval under the CE Mark for the JAZZ™ Standalone implant for posterior spinal fixation.
Implanet’s rodless fixation line launched in 2016 with the JAZZ Lock implant for the treatment of adult degenerative bone disorders. The JAZZ Standalone device utilizes the company’s JAZZ sublaminar Band platform, and can be incorporated into the JAZZ product range without new investments in equipment or surgeon training.
Sources: Implanet; ORTHOWORLD Inc.
Implanet received approval under the CE Mark for the JAZZ™ Standalone implant for posterior spinal fixation.
Implanet's rodless fixation line launched in 2016 with the JAZZ Lock implant for the treatment of adult degenerative bone disorders. The JAZZ Standalone device utilizes the company's JAZZ sublaminar Band platform, and can be...
Implanet received approval under the CE Mark for the JAZZ™ Standalone implant for posterior spinal fixation.
Implanet’s rodless fixation line launched in 2016 with the JAZZ Lock implant for the treatment of adult degenerative bone disorders. The JAZZ Standalone device utilizes the company’s JAZZ sublaminar Band platform, and can be incorporated into the JAZZ product range without new investments in equipment or surgeon training.
Sources: Implanet; ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





